Prestige Consumer Healthcare Inc PBH:NYSE

Last Price$42.36NYSE Closing Price as of 6:30PM ET 1/28/20

Today's Change+1.35(3.29%)
Bid (Size)$34.49 (2)
Ask (Size)N/A (N/A)
Day Low / High$41.26 - 42.43
Volume241.4 K
 

View Pharmaceuticals: Other IndustryPeer Comparison as of 01/28/2020

 

Prestige Consumer Healthcare Inc ( NYSE )

Price: $42.36
Change: +1.35 (3.29%)
Volume: 241.4 K
6:30PM ET 1/28/2020
 
 

Zogenix Inc ( NASDAQ )

Price: $50.51
Change: +1.08 (2.18%)
Volume: 404.8 K
4:00PM ET 1/28/2020
 
 

Ironwood Pharmaceuticals Inc ( NASDAQ )

Price: $12.38
Change: +0.20 (1.64%)
Volume: 922.4 K
3:59PM ET 1/28/2020
 
 

Pacira Biosciences Inc ( NASDAQ )

Price: $43.46
Change: -0.50 (1.14%)
Volume: 432.7 K
4:00PM ET 1/28/2020
 
 

Corcept Therapeutics Inc ( NASDAQ )

Price: $13.44
Change: +0.21 (1.55%)
Volume: 670.7 K
3:59PM ET 1/28/2020
 

Read more news Recent News

Research Alert: CFRA Lifts Sell Opinion On Shares Of Prestige Consumer Healthcare Inc. To Hold
8:50AM ET 1/17/2020 MT Newswires

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...

Prestige Consumer Healthcare Prices $400 Million Senior Notes
4:21PM ET 11/15/2019 MT Newswires

Prestige Consumer Healthcare (PBH), a maker of consumer healthcare products, said after markets closed on Friday that its unit, Prestige Brands, has priced...

Prestige Brand Holdings To Offer $400 Million In Senior Notes
10:02AM ET 11/15/2019 MT Newswires

Prestige Consumer Healthcare subsidiary Prestige Brand Holdings (PBH) said Friday that it plans to offer up to $400 million in aggregate principal amount...

Consensus for Prestige Consumer Healthcare Q1 and 2021 Targets Projected Higher
8:11AM ET 11/02/2019 MT Newswires

Prestige Consumer Healthcare Inc's December 31, 2019, quarterly and March 31, 2021 full year forecasted earnings estimates (NYSE:PBH, Recent Price: 35.46)...

Company Profile

Business DescriptionPrestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY. View company web site for more details
Address660 White Plains Road
Tarrytown, New York 10591
Phone+1.914.524.6800
Number of Employees520
Recent SEC Filing01/13/20208-K
Chairman, President & Chief Executive OfficerRonald M. Lombardi
Senior Vice President-OperationsJeff Zerillo
Chief Financial OfficerChristine Sacco
Senior Vice President-Science & TechnologyJean A. Boyko

Company Highlights

Price Open$41.26
Previous Close$41.01
52 Week Range$26.49 - 42.50
Market Capitalization$2.1 B
Shares Outstanding50.2 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement02/06/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share$2.45
Beta vs. S&P 500N/A
Revenue$975.8 M
Net Profit Margin-3.56%
Return on Equity-2.99%

Analyst Ratings as of 11/22/2019

Buy
2
Overweight
0
Hold
3
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset